Skip to main content
    A

    Aveanna Healthcare Holdings Inc (AVAH)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $11.63
    +0.13 (+1.13%)

    Market Cap: $2.51B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Aveanna Healthcare Holdings Inc (AVAH) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2026. Financial statements from company filings, amounts in US dollars.

    Aveanna Healthcare Holdings reported revenue of $2.43B for the fiscal year ended Dec 31, 2025, up 20.2% from the year before. That year, net income was $225.03M with a net margin of 9.2%, operating cash flow was $125.86M and free cash flow was $118.41M. The quarter ended Sep 30, 2026 had revenue of $695.54M and net income of $45.45M.

    Revenue and Margins

    The operating margin was 10.9% in the fiscal year ended Dec 2025, the highest of the 8 years shown. Over the 7 years to Dec 2025, revenue grew from $1.25B, a compound annual rate of 10.0%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$2.43B+20.2%33.1%10.9%9.2%
    Dec 2024$2.02B+6.8%31.4%6.9%-0.5%
    Dec 2023$1.90B+6.0%31.4%0.4%-7.1%
    Dec 2022$1.79B+6.5%30.9%-35.9%-37.0%
    Dec 2021$1.68B+12.3%32.3%-2.2%-7.0%
    Dec 2020$1.50B+8.0%30.4%-0.2%-3.8%
    Dec 2019$1.38B+10.4%30.3%2.8%-5.5%
    Dec 2018$1.25BN/A31.5%3.1%-3.8%
    Annual, fiscal years ended Dec 2018 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, net income rose 223.3% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Revenue$2.43B$2.02B$1.90B$1.79B$1.68B$1.50B$1.38B$1.25B
    Cost of revenue$1.63B$1.39B$1.30B$1.23B$1.14B$1.04B$964.81M$859.35M
    Gross profit$805.15M$635.54M$595.43M$553.23M$542.40M$454.51M$419.25M$394.32M
    Operating income$265.38M$139.79M$8.07M-$642.28M-$36.11M-$3.49M$38.95M$39.03M
    Net income$225.03M-$10.93M-$134.52M-$662.03M-$117.04M-$57.05M-$76.52M-$47.15M
    EBITDA$279.02M$187.38M$39.17M-$525.06M-$17.95M$61.47M$44.28M$96.11M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$695.54M$670.48M$647.91M$662.48M$621.94M$589.55M$559.22M$519.87M$509.02M$504.96M$490.65M$478.84M
    Gross profit$226.76M$218.53M$202.38M$210.57M$200.22M$210.80M$183.56M$171.72M$159.70M$158.27M$145.85M$148.45M
    Operating income$83.56M$79.98M$75.94M$77.27M$56.27M$80.03M$51.80M$45.77M$34.02M$37.13M$22.87M$29.29M
    Net income$45.45M$40.29M$41.65M$178.75M$14.06M$27.02M$5.19M$29.18M-$42.84M$13.91M-$11.17M-$25.74M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $1.49B exceeded cash and equivalents by $1.29B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Total assets$2.01B$1.66B$1.61B$1.71B$2.33B$1.84B$1.58B$1.55B
    Current assets$560.23M$392.67M$314.89M$269.75M$279.21M$340.64M$186.34M$214.93M
    Cash and equivalents$193.26M$84.29M$43.94M$19.22M$30.49M$137.34M$3.33M$8.00M
    Total liabilities$1.82B$1.79B$1.74B$1.72B$1.70B$1.58B$1.31B$1.21B
    Short-term debt$200.44M$198.60M$183.04M$28.45M$27.25M$24.67M$20.86M$9.40M
    Long-term debt$1.29B$1.27B$1.28B$1.28B$1.23B$1.16B$31.50MN/A
    Shareholder equity$195.19M-$122.09M-$127.44M-$4.17M$637.95M$267.17M$270.94M$344.99M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$2.21B$2.11B$2.02B$2.01B$1.81B$1.77B$1.66B$1.66B$1.64B$1.66B$1.64B$1.61B
    Total liabilities$1.87B$1.82B$1.78B$1.82B$1.80B$1.78B$1.76B$1.79B$1.80B$1.78B$1.78B$1.74B
    Cash and equivalents$197.84M$97.20M$189.27M$193.26M$145.87M$100.74M$71.49M$84.29M$78.46M$47.66M$42.61M$43.94M
    Shareholder equity$337.42M$287.28M$240.05M$195.19M$9.91M-$11.26M-$98.67M-$122.09M-$154.98M-$117.51M-$134.14M-$127.44M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 94.1% of operating cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow$125.86M$32.64M$22.67M-$48.40M-$11.35M$116.62M-$8.71M$21.60M
    Capital expenditures$7.45M$6.32M$6.12M$12.01M$15.95M$15.24M$16.64M$19.58M
    Free cash flow$118.41M$26.32M$16.56M-$60.41M-$27.30M$101.38M-$25.35M$2.02M
    Investing cash flow-$22.30M-$6.32M-$8.79M-$25.29M-$681.83M-$193.54M-$17.82M-$229.55M
    Financing cash flow$5.41M$14.03M$10.85M$62.42M$586.33M$210.94M$21.86M$204.15M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$72.25M$80.93M$4.35M$49.72M$33.20M$51.57M-$8.63M$13.41M$29.39M$1.81M-$11.97M-$3.00M
    Capital expenditures$1.91M$1.29M$4.56M$1.95M$2.02M$1.13M$2.35M$1.53M$2.21M$1.27M$1.31M$1.57M
    Free cash flow$70.34M$79.64M-$208.00K$47.77M$31.18M$50.44M-$10.98M$11.88M$27.18M$540.00K-$13.28M-$4.57M
    Last 12 quarters

    Frequently Asked Questions About AVAH

    What is Aveanna Healthcare Holdings' annual revenue?

    Aveanna Healthcare Holdings reported revenue of $2.43B for the fiscal year ended Dec 31, 2025.

    How fast is Aveanna Healthcare Holdings' revenue growing?

    Revenue was up 20.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 10.8%.

    Is Aveanna Healthcare Holdings profitable?

    Yes. Aveanna Healthcare Holdings reported net income of $225.03M for the fiscal year ended Dec 31, 2025, with a net margin of 9.2%.

    How much free cash flow does AVAH generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $125.86M minus capital expenditures of $7.45M produced free cash flow of $118.41M.

    How much debt does Aveanna Healthcare Holdings have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $1.29B, short-term debt of $200.44M and cash and equivalents of $193.26M.